Vedicinals

Vedicinals sells a small, science-formulated supplement line built around one flagship SKU: Vedicinals®9, a 90-capsule blend of nine bioactives (silymarin, quercetin, luteolin, curcumin, EGCG, resveratrol, NAC, zinc, and vitamin C). A 30-day bottle retails for $89 USD; bundles of three or six bottles drop the per-unit price to ≈$79 and $69, placing the brand in the premium tier. All commerce is direct-to-consumer through vedicinalsusa.com; no retail or marketplace listings are operated. The brand’s core claim is “advanced immune & detox support” backed by peer-reviewed mechanisms for each compound and third-party purity testing posted on-site. Vedicinals®9 is positioned as a one-and-done “synergistic complex” that replaces multiple single-ingredient bottles. Certificates of analysis, EU-patented phytosome technology for enhanced absorption, and a 30-day money-back guarantee are highlighted as proof-of-quality differentiators. Buyers are health-literate adults aged 35-65 who track PubMed, follow functional-medicine podcasts, and want research-grade ingredients without formulating their own stack. The audience skews toward professionals managing post-viral fatigue, environmental toxin exposure, or metabolic inflammation and who value transparent labeling over celebrity endorsement. Competitors include other single-formula “immune complexes” and high-end nootropic or longevity brands that combine polyphenols with antioxidants. Vedicinals differentiates by limiting the line to one clinically dosed, nine-ingredient matrix, publishing COAs for every lot, and avoiding subscription auto-ship gimmicks; the pitch is “precision formula, zero fluff.”